
Moberg Pharma Investor Relations Material
Latest events

Q4 2024
Moberg Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Moberg Pharma
Access all reports
Moberg Pharma AB develops, manufactures and markets OTC products in the areas of footcare and oral healthcare. The company own the rights to a patented platform technology, which means that they can tailor each product exactly to the needs of each customer. The products are primarily sold through intermediaries and are developed in close collaboration with leading retailers, who sell them on their home markets. Moberg Pharma AB market some of their products directly under their own brands, or via the company's own sales force on a limited number of selected markets.
Key slides for Moberg Pharma


Q4 2024
Moberg Pharma


Q4 2024
Moberg Pharma
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
MOB
Country
🇸🇪 Sweden